1H-Indole-2-carboxamide, 5-[2-(dimethylamino)ethoxy]-N-[3-[4-[(hydroxyamino)carbonyl]phenyl]-2-propyn-1-yl]-, hydrochloride (1:1);CRA-026440 hydrochloride;HDAC/BET-IN-1;CRA-026440 hydrochloride, 10 mM in DMSO
CRA-026440 hydrochloride exhibits antitumor and anti-angiogenic activities; it is a potent broad-spectrum histone deacetylase (HDAC) inhibitor targeting HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, and HDAC10.